Agios Reports Second Quarter 2018 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. LVS
6. SAP
7. CSX
8. LRCX
9. MRNA
10. SPCX

Go back to Agios Reports Second Quarter 2018 Financial Results

Agios Pharma (AGIO) PT Raised to $89 at Needham & Company

August 2, 2018 11:51 AM EDT

Needham & Company raised its price target on Agios Pharma (NASDAQ: AGIO) to $89.00 (from $86.00) while maintaining a Buy rating.

Analyst Chad Messer commented, "Both TIBSOVO and IDHIFA are now approved in relapsed/refractory AML. Agios is focused on moving both drugs into earlier... More

Agios Pharma (AGIO) Tops Q2 EPS by 36c

August 2, 2018 7:02 AM EDT

Agios Pharma (NASDAQ: AGIO) reported Q2 EPS of ($1.19), $0.36 better than the analyst estimate of ($1.55). Revenue for the quarter came in at $40.41 million versus the consensus estimate of $11.28 million.

For earnings history and earnings-related data on Agios Pharma (AGIO) click here.

... More